Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Transmedics Group Inc (NASDAQ: TMDX) closed at $127.69 in the last session, down -0.72% from day before closing price of $128.62. In other words, the price has decreased by -$0.72 from its previous closing price. On the day, 0.55 million shares were traded.
Ratios:
We take a closer look at TMDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.32 and its Current Ratio is at 9.10. In the meantime, Its Debt-to-Equity ratio is 1.95 whereas as Long-Term Debt/Eq ratio is at 1.94.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on December 17, 2024, Downgraded its rating to Neutral and sets its target price to $75 from $116 previously.
Oppenheimer reiterated its Outperform rating for the stock on October 29, 2024, while the target price for the stock was revised from $200 to $125.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 27 ’25 when Basile Edward M sold 5,000 shares for $126.45 per share. The transaction valued at 632,250 led to the insider holds 2,866 shares of the business.
EDWARD BASILE bought 5,000 shares of TMDX for $632,250 on May 27 ’25. On May 23 ’25, another insider, Weill David, who serves as the Director of the company, sold 732 shares for $123.88 each. As a result, the insider received 90,680 and left with 12,134 shares of the company.
Valuation Measures:
As of this moment, Transmedics’s Price-to-Earnings (P/E) ratio for their current fiscal year is 93.85, and their Forward P/E ratio for the next fiscal year is 51.24. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.85 while its Price-to-Book (P/B) ratio in mrq is 16.22.
Stock Price History:
Over the past 52 weeks, TMDX has reached a high of $177.37, while it has fallen to a 52-week low of $55.00. The 50-Day Moving Average of the stock is 37.85%, while the 200-Day Moving Average is calculated to be 29.94%.
Shares Statistics:
A total of 33.83M shares are outstanding, with a floating share count of 32.59M. Insiders hold about 3.69% of the company’s shares, while institutions hold 117.57% stake in the company.
